Prognostic and predictive factors of invasive ductal breast carcinomas

被引:0
|
作者
Lialiaris, T. S. [1 ]
Georgiou, G.
Sivridis, E. [2 ]
Kareli, D.
Tripsiannis, G. [3 ]
Papageorgiou, A. [4 ]
Chrisafi, S. [5 ]
Kritsi, Z. [5 ]
Giatromanolaki, A. [2 ]
机构
[1] Democritus Univ Thrace, Dept Genet, Sch Med, Genet Lab, Alexandroupolis 68100, Greece
[2] Democritus Univ Thrace, Pathol Lab, Sch Med, Alexandroupolis 68100, Greece
[3] Democritus Univ Thrace, Stat Lab, Sch Med, Alexandroupolis 68100, Greece
[4] Theagen Canc Hosp, Symeonid Res Ctr, Thessaloniki, Greece
[5] Aristotle Univ Thessaloniki, Lab Biol & Genet, Sch Med, GR-54006 Thessaloniki, Greece
来源
JOURNAL OF BUON | 2010年 / 15卷 / 01期
关键词
estrogen and progesterone receptors; E-cadherin; c-erbB-2; p53; primary ductal breast carcinoma; HORMONE-RECEPTOR; GAMMA-CATENIN; P53; MUTATIONS; E-CADHERIN; IN-SITU; CANCER; EXPRESSION; RISK; ESTROGEN; MARKERS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To investigate the significance of certain immunohistochemical markers, namely estrogen (ER) and progesterone receptors (PgR), c-erbB-2 oncogene, p53 tumor suppressor gene and E-cadherin adhesion molecule, in invasive ductal breast carcinomas. Methods: A series of 102 primary breast carcinomas of the ductal type and a standard immunohistochemical technique was used to detect the aforementioned biological markers. The findings were related to various clinical and pathological tumor characteristics, including lymph node metastases. Results: ER and E-cadherin were expressed more commonly in tumors of low histological grade and small number (<= 3) of metastatic lymph nodes, whereas c-erbB-2 and the p53 gene were usually expressed in breast tumors of high histological grade and increased number (>3) of metastatic lymph nodes. PgR, on the other hand, was detected frequently in patients with early menarche and metastases in <3 lymph nodes, but this tendency was not statistically significant. Conclusion: The use of these biomarkers, preferably in combination, may provide additional prognostic and therapeutic information which may he proved useful in planning breast cancer treatment.
引用
收藏
页码:79 / 88
页数:10
相关论文
共 50 条
  • [31] Correlation of MRI features and pathohistological prognostic factors in invasive ductal breast carcinoma
    Alduk, Ana Marija
    Brcic, Iva
    Podolski, Paula
    Prutki, Maja
    [J]. ACTA CLINICA BELGICA, 2017, 72 (05) : 306 - 312
  • [32] Re-Excision Rates of Invasive Ductal Carcinoma with Lobular Features Compared with Invasive Ductal Carcinomas and Invasive Lobular Carcinomas of the Breast
    Arps, David P.
    Jorns, Julie M.
    Zhao, Lili
    Bensenhaver, Jessica
    Kleer, Celina G.
    Pang, Judy C.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (13) : 4152 - 4158
  • [33] Re-Excision Rates of Invasive Ductal Carcinoma with Lobular Features Compared with Invasive Ductal Carcinomas and Invasive Lobular Carcinomas of the Breast
    David P. Arps
    Julie M. Jorns
    Lili Zhao
    Jessica Bensenhaver
    Celina G. Kleer
    Judy C. Pang
    [J]. Annals of Surgical Oncology, 2014, 21 : 4152 - 4158
  • [34] Scarff-Bloom-Richardson (SBR) grading: from predictive to prognostic significance in invasive ductal breast carcinomas treated by neoadjuvant chemotherapy (CT).
    Penault-Llorca, FM
    Amat, S
    De Latour, M
    Le Bouedec, G
    Achard, JL
    Van Praagh, I
    Feillel, V
    Dauplat, J
    Chollet, P
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S51 - S51
  • [35] Prognostic factors for invasive ductal pancreatic cancer
    Fujino, Y
    Suzuki, Y
    Ajiki, T
    Yoshikawa, T
    Kamigaki, T
    Takase, S
    Kuroda, Y
    [J]. Proceedings of the 40th Congress of the European Society for Surgical Research, 2005, : 53 - 56
  • [36] Predictive and prognostic value of sphingosine kinase 1 expression in patients with invasive ductal carcinoma of the breast
    Do, Sung-Im
    Kim, Hyun-Soo
    Kim, Kyungeun
    Lee, Hyunjoo
    Do, In-Gu
    Kim, Dong-Hoon
    Chae, Seoung Wan
    Sohn, Jin Hee
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2017, 9 (12): : 5684 - 5695
  • [37] Prognostic implications of miR-21 and miR-210 overexpression in invasive ductal carcinomas of the breast
    Lee, J. A.
    Lee, H. Y.
    Lee, E. S.
    Kim, I. S.
    Bae, J. W.
    [J]. BREAST, 2011, 20 : S46 - S46
  • [38] The lectin-binding sites for peanut agglutinin in invasive breast ductal carcinomas and their role as a prognostic factor
    Mustac, E
    Melato, M
    Sasso, F
    Valkovic, T
    Bottin, C
    Jonjic, N
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1996, 122 (11) : 693 - 697
  • [39] Prognostic factors for patients with invasive ductal carcinoma of the breast who received neoadjuvant chemotherapy
    Tamura, N.
    [J]. BREAST, 2009, 18 : S33 - S33
  • [40] Prognostic factors for patients with invasive ductal carcinoma of the breast who received neoadjuvant chemotherapy
    Tamura, N.
    Tamura, N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)